Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Belatacept may be a promising treatment for alopecia areata.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Using Excimer light with topical steroids is the most effective treatment for alopecia areata.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.